Mimedx (MDXG) Share-based Compensation Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -34.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.52% |
| Dec 31, 2025 | 66.88% |
| Sep 30, 2025 | 27.52% |
| Jun 30, 2025 | 2.38% |
| Mar 31, 2025 | 2.15% |
| Dec 31, 2024 | 15.56% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | 0.25% |
| Mar 31, 2024 | 10.19% |
| Dec 31, 2023 | 3.95% |
| Sep 30, 2023 | 6.15% |
| Jun 30, 2023 | -2.89% |
| Mar 31, 2023 | 5.24% |
| Dec 31, 2022 | -43.02% |
| Sep 30, 2022 | -4.06% |
| Jun 30, 2022 | 8.17% |
| Mar 31, 2022 | 9.88% |
| Dec 31, 2021 | 27.80% |
| Sep 30, 2021 | -1.25% |
| Jun 30, 2021 | -2.81% |
| Mar 31, 2021 | -13.03% |
| Dec 31, 2020 | -13.16% |
| Sep 30, 2020 | -11.57% |
| Jun 30, 2020 | -5.51% |
| Mar 31, 2020 | -10.50% |
| Dec 31, 2019 | -9.82% |
| Sep 30, 2019 | -17.03% |
| Jun 30, 2019 | -8.11% |
| Mar 31, 2019 | -13.24% |
| Dec 31, 2018 | -30.46% |
| Sep 30, 2018 | -3.31% |
| Jun 30, 2018 | 1.31% |
| Mar 31, 2018 | 7.83% |
| Dec 31, 2017 | 21.90% |
| Sep 30, 2017 | 20.64% |
| Jun 30, 2017 | 23.84% |
| Mar 31, 2017 | 25.34% |
| Dec 31, 2016 | 28.17% |
| Sep 30, 2016 | 41.27% |
| Jun 30, 2016 | 44.24% |
| Mar 31, 2016 | 67.34% |
| Dec 31, 2015 | 76.84% |
| Sep 30, 2015 | 87.00% |
| Jun 30, 2015 | 93.70% |
| Mar 31, 2015 | 98.75% |
| Dec 31, 2014 | 73.82% |
| Sep 30, 2014 | 138.49% |
| Jun 30, 2014 | 86.13% |
| Mar 31, 2014 | 84.06% |